PABPC4 Antibody

What is PABPC4 and why is it important in molecular biology research?

PABPC4, also known as Poly(A) Binding Protein Cytoplasmic 4 (Inducible Form), is a member of the cytoplasmic poly(A) binding protein family that plays important roles in post-transcriptional regulation. It is particularly noteworthy because studies have shown that PABPC4 can compensate for the partial loss of PABPC1, the predominant isoform of cytoplasmic PABP in cells . When PABPC1 is truncated or decreased, PABPC4 expression can be elevated approximately two-fold at both protein and mRNA levels . PABPC4 also serves a critical role in erythroid cells, impacting the steady-state expression of a subset of erythroid mRNAs . This makes it an important target for research into RNA regulation, particularly in specialized cell types.

What applications are PABPC4 antibodies commonly used for?

PABPC4 antibodies are versatile tools primarily used in several key molecular and cellular techniques:

• Western Blotting (WB): For detecting and quantifying PABPC4 protein in cell or tissue lysates

• Immunohistochemistry (IHC): For visualizing PABPC4 expression in tissue sections

• Immunofluorescence (IF/ICC): For determining subcellular localization of PABPC4 in cultured cells

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of PABPC4 in solution

• Immunoprecipitation (IP): For isolating PABPC4 and associated complexes

The choice of application should be guided by the specific research question, with appropriate controls and validation to ensure specificity.

What is the typical reactivity spectrum of commercially available PABPC4 antibodies?

Most commercially available PABPC4 antibodies show cross-reactivity across multiple species, with human, mouse, and rat being the most common. According to the search results, various antibodies have different reactivity profiles:

• Some antibodies react with human, mouse, and rat samples

• Others have broader reactivity, including human, mouse, rat, dog, horse, monkey, and bat

• Some are more specific to human samples

This cross-reactivity information is crucial when selecting an antibody for your research model. When working with less common species, it's advisable to perform validation experiments or seek antibodies with documented reactivity to your species of interest.

How should researchers compare PABPC4 and PABPC1 expression in the same experimental system?

When comparing PABPC4 and PABPC1 expression, a multi-faceted approach is recommended:

• Protein level analysis: Use western blotting with specific antibodies targeting unique regions of each protein. For PABPC4, antibodies targeting regions like AA 350-450 are available . For PABPC1, antibodies from providers like Abcam (ab21060), Cell Signaling (4992), or Santa Cruz (sc32318) have been successfully used .

• mRNA expression analysis: Implement quantitative RT-PCR with isoform-specific primers. As demonstrated in studies where PABPC1 was edited using CRISPR/Cas9, changes in PABPC4 mRNA levels could be quantified in response to PABPC1 reduction .

• Experimental manipulations: Consider creating cell lines with modified PABPC1 expression (via CRISPR/Cas9) to observe compensatory changes in PABPC4. In HEK293 cells, a two-fold elevation of PABPC4 at both protein and mRNA levels was observed when PABPC1 was truncated and decreased .

• Controls: Include housekeeping genes/proteins such as GAPDH, tubulin, or 18S rRNA for normalization .

This comprehensive approach allows for robust analysis of the relationship between these two poly(A) binding proteins.

What considerations are important when selecting a PABPC4 antibody for studying its role in erythroid differentiation?

When studying PABPC4's role in erythroid differentiation, several critical factors should guide antibody selection:

• Epitope location: Choose antibodies targeting conserved regions if comparing across species, or unique regions to distinguish from other PABP family members. The available PABPC4 antibodies target various regions including AA 350-450, which contains the sequence "VTEMNGRIVG SKPLYVALAQ RKEERKAHLT NQYMQRVAGM RALPANAILN QFQPAAGGYF VPAVPQAQGR PPYYTPNQLA QMRPNPRWQQ GGRPQGFQGM P" .

• Validation in erythroid models: Prioritize antibodies with documented use in erythroid cell lines or tissues. Research has demonstrated that PABPC4 plays a critical role in erythroid cells and impacts the steady-state expression of erythroid mRNAs .

• Application compatibility: Ensure the antibody is validated for your specific applications. For example, if studying subcellular localization during differentiation, confirm IF/ICC validation .

• Species reactivity: Match the antibody's reactivity to your experimental model. Most PABPC4 antibodies react with human, mouse, and rat samples, which is important if using MEL cells or other model systems .

• Controls: Include appropriate positive controls (cells known to express PABPC4) and negative controls (knockdown cells) to validate specificity.

For erythroid studies specifically, consider antibodies that have been documented to work in MEL cell systems, as these are frequently used for erythroid differentiation studies .

How does PABPC4 compensation for PABPC1 loss affect experimental design when studying translation regulation?

The compensatory relationship between PABPC4 and PABPC1 presents both challenges and opportunities for translation regulation studies:

• Dual knockdown/knockout approaches: When targeting PABPC1, researchers should consider that PABPC4 may compensate, potentially masking phenotypes. In HEK293 cells with CRISPR/Cas9-edited PABPC1, there was an approximate two-fold elevation of PABPC4 at both protein and mRNA levels . Studies may require simultaneous knockdown of both proteins for complete functional analysis.

• Expression monitoring: Experiments should include monitoring of both PABPC1 and PABPC4 levels, as changes in one may affect the other. This can be accomplished through western blotting using specific antibodies for each protein .

• Functional redundancy assessment: Research designs should include assays to determine the extent of functional redundancy between these proteins. This might involve rescue experiments where PABPC4 overexpression is tested for its ability to complement PABPC1 deficiency .

• Cell line selection: Consider the baseline expression of both proteins in your model system. In some engineered cell lines like clone-c1c4, PABPC4 becomes the major PABP isoform instead of PABPC1 .

• mRNA target specificity: Design experiments to identify whether certain mRNAs are preferentially regulated by PABPC1 versus PABPC4, as suggested by research in erythroid cells where PABPC4 impacts a specific subset of mRNAs .

These considerations will help researchers more accurately interpret results when studying translation processes affected by poly(A) binding proteins.

What are the optimal conditions for using PABPC4 antibodies in Western blotting?

For optimal Western blotting using PABPC4 antibodies, follow these methodological guidelines:

• Sample preparation:

  • Heat protein samples at 95°C in standard SDS loading buffer

  • Separate by SDS-PAGE using an appropriate percentage gel (10-12% is typically suitable for PABPC4's ~70 kDa size)

• Transfer conditions:

  • Transfer to PVDF membrane in Tris/Glycine buffer with 20% methanol at 4°C

  • Cold transfer is recommended to improve retention of high molecular weight proteins

• Blocking:

  • Block membrane in TBST (pH 7.5) containing 0.05% Tween-20

  • Use either 5% skim milk powder or bovine serum albumin for blocking

• Primary antibody incubation:

  • Dilute PABPC4 antibody according to manufacturer recommendations (typical range 1:1000)

  • Incubate overnight at 4°C for best results

• Secondary antibody:

  • For rabbit host primary antibodies, use goat-anti-rabbit secondary (e.g., Jackson ImmunoResearch 111-035-046, 1:5000)

  • Incubate for 0.5-1 hour at room temperature

• Detection:

  • Develop with ECL reagent (such as Amersham ECL prime kit)

  • Image using a digital imaging system

• Controls:

  • Include positive control (tissue/cells known to express PABPC4)

  • Include loading control (tubulin, GAPDH)

  • Consider PABPC1 detection in parallel for comparative analysis

These conditions can be optimized based on the specific antibody and experimental system.

How can researchers validate the specificity of their PABPC4 antibody?

Validating PABPC4 antibody specificity is crucial for experimental rigor. Implement these validation methods:

• Genetic approaches:

  • Use CRISPR/Cas9 to generate PABPC4 knockout cell lines as negative controls

  • Alternatively, use siRNA or shRNA to knockdown PABPC4 expression

  • Compare antibody signal between wild-type and knockout/knockdown samples

• Overexpression controls:

  • Transfect cells with PABPC4 expression constructs (such as pFRT/TO/FLAG/HA-DEST PABPC4)

  • Verify increased signal intensity in overexpressing cells

• Peptide competition:

  • Pre-incubate antibody with the immunizing peptide (if available)

  • Confirm signal reduction when the antibody is blocked by its specific target

• Cross-reactivity assessment:

  • Test antibody against recombinant PABPC1 and other PABP family members

  • Ensure the antibody distinguishes between closely related proteins

• Multiple antibody comparison:

  • Use antibodies targeting different epitopes of PABPC4 (e.g., AA 350-450, N-terminal, or internal regions)

  • Consistent results with different antibodies increase confidence in specificity

• Multiple techniques:

  • Confirm results across complementary techniques (Western blot, IHC, IF)

  • Each method provides different information about specificity

This comprehensive validation approach ensures reliable results and facilitates troubleshooting if unexpected observations arise.

What is the recommended protocol for immunofluorescence detection of PABPC4 in cultured cells?

For optimal immunofluorescence detection of PABPC4, follow this detailed protocol:

• Cell preparation:

  • Culture cells on sterilized glass coverslips in appropriate medium

  • For transfection experiments, transfect cells 24 hours prior, then trypsin digest and split onto coverslides

• Fixation and permeabilization:

  • Fix cells with 4% paraformaldehyde in PBS for 15 minutes at room temperature

  • Permeabilize with 0.2% Triton X-100 in PBS for 10 minutes

• Blocking:

  • Block with 5% normal serum (matching secondary antibody host) in PBS for 30-60 minutes

• Primary antibody:

  • Dilute PABPC4 antibody at 1:50 to 1:200 in blocking solution

  • Incubate overnight at 4°C in a humidified chamber

• Washing:

  • Wash 3x with PBS for 5 minutes each

• Secondary antibody:

  • Apply fluorophore-conjugated secondary antibody (appropriate to primary host)

  • Typical dilution 1:200-1:500 in blocking solution

  • Incubate for 1 hour at room temperature in the dark

• Counterstaining:

  • Counterstain nuclei with DAPI (1:1000 in PBS) for 5 minutes

  • Perform additional washes to remove excess DAPI

• Mounting:

  • Mount coverslips on slides using anti-fade mounting medium

  • Seal edges with nail polish

• Controls and optimization:

  • Include negative controls (primary antibody omission)

  • Optimize antibody concentration for your specific cell type

  • Note that optimal dilutions should be determined by the end user

• Storage:

  • Store slides at 4°C in the dark until imaging

  • Image within 1-2 weeks for best results

This protocol can be adjusted based on cell type and specific experimental requirements.

How should researchers interpret changes in PABPC4 expression in response to cellular stress or differentiation?

Interpreting changes in PABPC4 expression requires careful consideration of several factors:

By integrating these analytical approaches, researchers can more accurately interpret the biological significance of PABPC4 expression changes in their experimental systems.

What are the main challenges and solutions when detecting low abundance PABPC4 in tissue samples?

Detecting low abundance PABPC4 in tissues presents several challenges with corresponding solutions:

For IHC applications specifically, recommended dilutions of 1/50 to 1/200 have been suggested , but optimizing the protocol for each specific tissue type is essential. Additionally, proper tissue fixation and processing are critical for preserving PABPC4 antigenicity in histological specimens.

What experimental controls are essential when studying PABPC4's functional compensation for PABPC1?

When investigating PABPC4's compensatory relationship with PABPC1, these essential controls should be incorporated:

• Expression level controls:

  • Wild-type cells with normal PABPC1/PABPC4 ratios

  • PABPC1 knockout/knockdown cells to observe natural compensation

  • PABPC4 knockout/knockdown cells to confirm specific functions

  • Double knockdown cells to observe complete loss of function

• Rescue experiments:

  • PABPC1-deficient cells with exogenous PABPC4 expression

  • PABPC1-deficient cells with exogenous PABPC1 expression (positive control)

  • Expression constructs should be carefully designed (e.g., pFRT/TO/FLAG/HA-DEST PABPC4)

• Domain-specific controls:

  • Truncation mutants (like PABPC1ΔMLLE) to determine which domains are required for functional compensation

  • Chimeric proteins containing domains from both proteins

• Functional readouts:

  • mRNA stability assays for known PABP-dependent transcripts

  • Translation efficiency measurements

  • Growth and viability assessments under different conditions

• Technical controls:

  • Multiple antibodies targeting different PABPC4 epitopes to confirm specificity

  • Housekeeping genes/proteins (GAPDH, tubulin, 18S rRNA) for normalization

  • Time course experiments to capture dynamic compensation

This comprehensive control strategy will allow researchers to rigorously establish the extent and mechanism of PABPC4's compensatory function for PABPC1.

How might new antibody technologies improve PABPC4 research in the coming years?

Emerging antibody technologies are poised to advance PABPC4 research in several ways:

• Super-resolution compatible antibodies: Development of antibodies optimized for techniques like STORM, PALM, and STED microscopy will enable nanoscale visualization of PABPC4's subcellular distribution and interactions with RNA and other proteins.

• Live-cell imaging probes: Creation of cell-permeable antibody fragments or nanobodies against PABPC4 will allow real-time tracking of this protein during cellular processes without fixation artifacts.

• Proximity labeling antibodies: Antibodies conjugated to enzymes like APEX2, BioID, or TurboID will facilitate identification of PABPC4's molecular neighborhood in different cellular contexts.

• Dual-targeting antibodies: Bispecific antibodies targeting PABPC4 and PABPC1 simultaneously will enable better studies of their co-localization and potential functional redundancy .

• Epitope-specific degraders: Antibody-based targeted protein degradation approaches (PROTAC-like) could allow selective degradation of PABPC4 without affecting PABPC1, despite their sequence similarity.

• Single-cell antibody technologies: Improvements in single-cell Western blotting and imaging mass cytometry will allow researchers to examine PABPC4 expression heterogeneity within tissues and cell populations.

These technological advances will facilitate more sophisticated interrogation of PABPC4's functions in normal physiology and disease conditions, particularly in specialized contexts like erythroid cells .

What are the most promising research applications for PABPC4 antibodies beyond traditional techniques?

Beyond traditional applications, PABPC4 antibodies show promise in several innovative research areas:

• Spatial transcriptomics: Combining PABPC4 antibodies with in situ RNA sequencing can reveal the spatial organization of PABPC4-associated mRNAs in tissues, providing insights into compartmentalized translation regulation.

• Extracellular vesicle (EV) analysis: As RNA-binding proteins can be packaged into EVs, PABPC4 antibodies could be used to study its presence in exosomes and other vesicles, potentially revealing new intercellular communication mechanisms.

• Riboproteomics: PABPC4 antibodies can be employed in techniques like eCLIP or PAR-CLIP to identify the specific RNA targets of PABPC4 versus PABPC1, especially in contexts like erythroid cells where PABPC4 impacts specific mRNAs .

• Dynamic interactome mapping: Using PABPC4 antibodies in proximity labeling approaches can help map how its protein interaction network changes during cellular processes like stress response or differentiation.

• Translation dynamics: Antibodies against PABPC4 can be used in ribosome profiling studies to understand how it influences translation efficiency of specific mRNAs, particularly in cells where it compensates for PABPC1 reduction .

• Developmental biology: Given PABPC4's role in erythroid cells , antibodies can help track its expression during hematopoietic development and lineage specification.

These emerging applications highlight the versatility of PABPC4 antibodies as tools for understanding complex biological processes beyond their conventional uses in protein detection.